Literature DB >> 26819207

Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.

Ling Wei1, Ju-Jie Sun2, Yong-Chun Cui3, Shu-Li Jiang4, Xing-Wu Wang1, Li-Yan Lv1, Li Xie1, Xian-Rang Song5.   

Abstract

Hypoxia promotes tumor invasion and metastasis via multiple mechanisms, including epithelial-mesenchymal transition (EMT). Twist, an EMT regulator, has been disclosed to associate with invasion and metastasis as well as poor prognosis of many malignancies. However, it remains undefined whether Twist is involved in invasion and metastasis of hypoxic non-small cell lung cancer (NSCLC). In this study, protein levels of Twist, hypoxia-inducible factor-1α (HIF-1α), and EMT markers (E-cadherin and vimentin) were examined by immunohistochemistry in 76 lung cancer tissues from NSCLC patients. Expression of Twist and its correlation with HIF-1α, E-cadherin, and vimentin were analyzed. Small interfering RNA (siRNA) against Twist was used to knockdown Twist expression in hypoxic NSCLC cells, A549 and NCI-H460. Cellular invasion and protein levels of Twist, E-cadherin, and vimentin were evaluated by matrigel invasion assay and Western blot, respectively. Our results showed that in clinical samples, there was a significant association between Twist expression and differentiation degree, lymph node metastasis, and TNM stage. Correlation analysis demonstrated that expression of Twist was negatively correlated with E-cadherin expression, but positively associated with HIF-1α and vimentin expression. In cultured NSCLC cells, Twist messenger RNA (mRNA) and protein levels were upregulated under hypoxia, while knockdown of Twist suppressed potentiated invasion and expression of mesenchymal marker vimentin induced by hypoxia. Protein level of increased epithelial marker E-cadherin was shown along with Twist downregulation. These findings suggest that Twist promoting hypoxic invasion and metastasis of NSCLC may be associated with altered expression of EMT markers. Inhibition of Twist may be of therapeutic significance.

Entities:  

Keywords:  Epithelial-mesenchymal transition; Hypoxia; Invasion; Metastasis; Non-small cell lung cancer; Twist

Mesh:

Substances:

Year:  2016        PMID: 26819207     DOI: 10.1007/s13277-016-4896-2

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  31 in total

1.  Nuclear expression of Twist promotes lymphatic metastasis in esophageal squamous cell carcinoma.

Authors:  Taiqian Gong; Zengfu Xue; Shanhong Tang; Xiushan Zheng; Guanghui Xu; Liucun Gao; Guohong Zhao; Liu Hong; Guangbo Tang; Hongwei Zhang; Ruwen Wang; Yaoguang Jiang; Daiming Fan
Journal:  Cancer Biol Ther       Date:  2012-06-01       Impact factor: 4.742

2.  Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer.

Authors:  Yelena Mironchik; Paul T Winnard; Farhad Vesuna; Yoshinori Kato; Flonne Wildes; Arvind P Pathak; Scott Kominsky; Dmitri Artemov; Zaver Bhujwalla; Paul Van Diest; Horst Burger; Carlotta Glackin; Venu Raman
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

3.  Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer.

Authors:  Farhad Vesuna; Paul van Diest; Ji Hshiung Chen; Venu Raman
Journal:  Biochem Biophys Res Commun       Date:  2007-12-04       Impact factor: 3.575

4.  Twist1 in tumor cells and α-smooth muscle actin in stromal cells are possible biomarkers for metastatic giant basal cell carcinoma.

Authors:  Sei-ichiro Motegi; Kazuya Yamada; Osamu Ishikawa
Journal:  J Dermatol       Date:  2013-05-19       Impact factor: 4.005

5.  Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.

Authors:  Fariz Nurwidya; Fumiyuki Takahashi; Isao Kobayashi; Akiko Murakami; Motoyasu Kato; Kunihiko Minakata; Takeshi Nara; Muneaki Hashimoto; Shigehiro Yagishita; Hario Baskoro; Moulid Hidayat; Naoko Shimada; Kazuhisa Takahashi
Journal:  Biochem Biophys Res Commun       Date:  2014-11-15       Impact factor: 3.575

6.  Upregulation of Twist in gastric carcinoma associated with tumor invasion and poor prognosis.

Authors:  Guo-Qing Ru; Hui-Ju Wang; Wen-Jun Xu; Zhong-Sheng Zhao
Journal:  Pathol Oncol Res       Date:  2010-11-23       Impact factor: 3.201

7.  Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.

Authors:  Terence K Lee; Ronnie T P Poon; Anthony P Yuen; Ming Tat Ling; Wei Kei Kwok; Xiang Hong Wang; Yong Chuan Wong; Xin Yuan Guan; Kwan Man; King Lok Chau; Sheung Tat Fan
Journal:  Clin Cancer Res       Date:  2006-09-15       Impact factor: 12.531

8.  Involvement of the transcription factor twist in phenotype alteration through epithelial-mesenchymal transition in lung cancer cells.

Authors:  Harunori Nakashima; Naozumi Hashimoto; Daisuke Aoyama; Takashi Kohnoh; Koji Sakamoto; Masaaki Kusunose; Kazuyoshi Imaizumi; Yoshihiro Takeyama; Mitsuo Sato; Tsutomu Kawabe; Yoshinori Hasegawa
Journal:  Mol Carcinog       Date:  2011-05-18       Impact factor: 4.784

9.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.

Authors:  Li Ma; Julie Teruya-Feldstein; Robert A Weinberg
Journal:  Nature       Date:  2007-09-26       Impact factor: 49.962

10.  Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma.

Authors:  Yongli Shi; Hongyan Wu; Mingyi Zhang; Lei Ding; Fanqing Meng; Xiangshan Fan
Journal:  Diagn Pathol       Date:  2013-05-24       Impact factor: 2.644

View more
  20 in total

1.  Hypoxia-induced epithelial to mesenchymal transition in cancer.

Authors:  Robert Y Hapke; Scott M Haake
Journal:  Cancer Lett       Date:  2020-05-26       Impact factor: 8.679

2.  Identification and Development of Subtypes with Poor Prognosis in Gastric Cancer Based on Both Hypoxia and Immune Cell Infiltration.

Authors:  Yao Wang; Jingjing Sun; Yang Yang; Sonia Zebaze Dongmo; Yeben Qian; Zhen Wang
Journal:  Int J Gen Med       Date:  2021-12-06

Review 3.  Metastasis prevention: targeting causes and roots.

Authors:  A A Schegoleva; A A Khozyainova; T S Gerashchenko; L D Zhuikova; Evgeny V Denisov
Journal:  Clin Exp Metastasis       Date:  2022-03-26       Impact factor: 4.510

4.  CSF-1R regulates non-small cell lung cancer cells dissemination through Wnt3a signaling.

Authors:  Yan Xia Yu; Hai Jian Wu; Bing Xu Tan; Chen Qiu; Hui Zhong Liu
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

Review 5.  Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression.

Authors:  Debashree Basudhar; Veena Somasundaram; Graciele Almeida de Oliveira; Aparna Kesarwala; Julie L Heinecke; Robert Y Cheng; Sharon A Glynn; Stefan Ambs; David A Wink; Lisa A Ridnour
Journal:  Antioxid Redox Signal       Date:  2016-09-07       Impact factor: 8.401

6.  [Twist regulates proliferation, migration and invasion of osteosarcoma cells in vitro].

Authors:  Yun He; Shu-Yu Fang; Yang Bi; Tong-Chuan He; Yi Wang; Si-Qi Hong
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-05-20

7.  Deficiency of protein-L-isoaspartate (D-aspartate) O-methyl-transferase expression under endoplasmic reticulum stress promotes epithelial mesenchymal transition in lung adenocarcinoma.

Authors:  Masahiro Yamashita; Masahito Ogasawara; Yasushi Kawasaki; Miyuki Niisato; Heisuke Saito; Shuya Kasai; Chihaya Maesawa; Makoto Maemondo; Kohei Yamauchi
Journal:  Oncotarget       Date:  2018-01-27

Review 8.  Novel Molecular Markers for Breast Cancer.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Biomark Cancer       Date:  2016-03-13

9.  Clinicopathological and prognostic significance of Twist overexpression in NSCLC.

Authors:  Meng Li; Xing Zhang; Xiaoqing Xu; Jiubin Wu; Kaiwen Hu; Xiuwei Guo; Peitong Zhang
Journal:  Oncotarget       Date:  2018-02-14

10.  GRK6 Depletion Induces HIF Activity in Lung Adenocarcinoma.

Authors:  Sumei Yao; Ayse Ertay; Yilu Zhou; Liudi Yao; Charlotte Hill; Jinliang Chen; Yangbo Guan; Hui Sun; Rob M Ewing; Yifei Liu; Xuedong Lv; Yihua Wang
Journal:  Front Oncol       Date:  2021-05-31       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.